Dizzy Liquid
NDC Package 43742-1675-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dizzy (cerebellum (suis), bryonia (alba), petroleum, tabacum, ambra grisea, cyclamen europaeum, natrum salicylicum, argentum nitricum, asarum canadense, calcarea sulphurica, carboneum sulphuratum, chininum sulphuricum, cocculus indicus, conium maculatum, digitalis purpurea, gelsemium sempervirens, phosphorus, piper methysticum, silicea, theridion) liquids is for temporary relief of symptoms of vertigo such as faintness, vomiting, motion sickness, spinning or swaying sensation and weakness.****These statements are based upon homeopathic principles. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-1675.

Identification & Billing

NDC Package Code
43742-1675-1
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
43742-1675
11-Digit Billing Format
43742167501

Clinical Specifications

Proprietary Name
Dizzy
Non-Proprietary Name
Cerebellum (suis), Bryonia (alba), Petroleum, Tabacum, Ambra Grisea, Cyclamen Europaeum, Natrum Salicylicum, Argentum Nitricum, Asarum Canadense, Calcarea Sulphurica, Carboneum Sulphuratum, Chininum Sulphuricum, Cocculus Indicus, Conium Maculatum, Digitalis Purpurea, Gelsemium Sempervirens, Phosphorus, Piper Methysticum, Silicea, Theridion
Substance Name
Sus Scrofa Cerebrum; Bryonia Alba Root; Kerosene; Tobacco Leaf; Ambergris; Cyclamen Purpurascens Tuber; Sodium Salicylate; Silver Nitrate; Asarum Canadense Root; Calcium Sulfate Anhydrous; Carbon Disulfide; Quinine Sulfate; Anamirta Cocculus Seed; Conium Maculatum Flowering Top; Digitalis; Gelsemium Sempervirens Root; Phosphorus; Macropiper Methysticum Root; Silicon Dioxide; Theridion Curassavicum
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
For temporary relief of symptoms of vertigo such as faintness, vomiting, motion sickness, spinning or swaying sensation and weakness.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration. For temporary relief of symptoms of vertigo such as faintness, vomiting, motion sickness, spinning or swaying sensation and weakness.****These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Regulatory & Marketing

Labeler Name
Deseret Biologicals, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-22-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43742-1675-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Dizzy, a human over the counter drug labeled by Deseret Biologicals, Inc.. This liquid is formulated for oral use and contains sus scrofa cerebrum; bryonia alba root; kerosene; tobacco leaf; ambergris; cyclamen purpurascens tuber; sodium salicylate; silver nitrate; asarum canadense root; calcium sulfate anhydrous; carbon disulfide; quinine sulfate; anamirta cocculus seed; conium maculatum flowering top; digitalis; gelsemium sempervirens root; phosphorus; macropiper methysticum root; silicon dioxide; theridion curassavicum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on September 22, 2020. The current certification is valid through December 31, 2026.

How is this Deseret Biologicals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742167501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43742-1675-1
11-Digit CMS (5-4-2)
43742-1675-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.